NCT05198336View on ClinicalTrials.gov

Immunogenicity of an Inactivated COVID-19 Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

January 8, 2022

Primary Completion Date

January 24, 2022

Study Completion Date

December 30, 2022

Conditions
COVID-19
Interventions
BIOLOGICAL

Inactivated COVID-19 Vaccine

600SU inactivated virus in 0.5 mL of aluminium hydroxide solution per injection

Trial Locations (1)

250014

Rushan City Center for Disease Control and Prevention, Weihai

All Listed Sponsors
lead

Sinovac Research and Development Co., Ltd.

INDUSTRY

NCT05198336 - Immunogenicity of an Inactivated COVID-19 Vaccine | Biotech Hunter | Biotech Hunter